179 related articles for article (PubMed ID: 28726775)
1. Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression.
Wei L; Dai Y; Zhou Y; He Z; Yao J; Zhao L; Guo Q; Yang L
Cell Death Dis; 2017 Jul; 8(7):e2944. PubMed ID: 28726775
[TBL] [Abstract][Full Text] [Related]
2. Pyruvate kinase M2 interacts with nuclear sterol regulatory element-binding protein 1a and thereby activates lipogenesis and cell proliferation in hepatocellular carcinoma.
Zhao X; Zhao L; Yang H; Li J; Min X; Yang F; Liu J; Huang G
J Biol Chem; 2018 Apr; 293(17):6623-6634. PubMed ID: 29514980
[TBL] [Abstract][Full Text] [Related]
3. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
[TBL] [Abstract][Full Text] [Related]
4. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract][Full Text] [Related]
5. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q
Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876
[TBL] [Abstract][Full Text] [Related]
6. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
[TBL] [Abstract][Full Text] [Related]
7. Ectosomal PKM2 Promotes HCC by Inducing Macrophage Differentiation and Remodeling the Tumor Microenvironment.
Hou PP; Luo LJ; Chen HZ; Chen QT; Bian XL; Wu SF; Zhou JX; Zhao WX; Liu JM; Wang XM; Zhang ZY; Yao LM; Chen Q; Zhou D; Wu Q
Mol Cell; 2020 Jun; 78(6):1192-1206.e10. PubMed ID: 32470318
[TBL] [Abstract][Full Text] [Related]
8. COX-2 induces apoptosis-resistance in hepatocellular carcinoma cells via the HIF-1α/PKM2 pathway.
Wang Q; Lu D; Fan L; Li Y; Liu Y; Yu H; Wang H; Liu J; Sun G
Int J Mol Med; 2019 Jan; 43(1):475-488. PubMed ID: 30365092
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer.
Taniguchi K; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakagawa Y; Ito Y; Otsuki Y; Uno B; Uchiyama K; Akao Y
Cancer Lett; 2015 Jul; 363(1):17-27. PubMed ID: 25818238
[TBL] [Abstract][Full Text] [Related]
10. SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma.
Tai WT; Hung MH; Chu PY; Chen YL; Chen LJ; Tsai MH; Chen MH; Shiau CW; Boo YP; Chen KF
Oncotarget; 2016 Apr; 7(16):22193-205. PubMed ID: 26959741
[TBL] [Abstract][Full Text] [Related]
11. Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a:HK2/PKM2 modulation.
Li W; Qiu Y; Hao J; Zhao C; Deng X; Shu G
Food Chem Toxicol; 2018 Nov; 121():156-165. PubMed ID: 30171973
[TBL] [Abstract][Full Text] [Related]
12. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma.
Dayton TL; Gocheva V; Miller KM; Israelsen WJ; Bhutkar A; Clish CB; Davidson SM; Luengo A; Bronson RT; Jacks T; Vander Heiden MG
Genes Dev; 2016 May; 30(9):1020-33. PubMed ID: 27125672
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
[TBL] [Abstract][Full Text] [Related]
14. Organ-Specific MicroRNAs (
Taniguchi K; Sugito N; Shinohara H; Kuranaga Y; Inomata Y; Komura K; Uchiyama K; Akao Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695138
[TBL] [Abstract][Full Text] [Related]
15. A novel human hepatoma cell line, FLC-4, exhibits highly enhanced liver differentiation functions through the three-dimensional cell shape.
Laurent T; Murase D; Tsukioka S; Matsuura T; Nagamori S; Oda H
J Cell Physiol; 2012 Jul; 227(7):2898-906. PubMed ID: 21960466
[TBL] [Abstract][Full Text] [Related]
16. Activators of PKM2 in cancer metabolism.
Warner SL; Carpenter KJ; Bearss DJ
Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
[TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate enhances STAT 1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha.
Hung WC; Chuang LY
Br J Cancer; 1999 May; 80(5-6):705-10. PubMed ID: 10360647
[TBL] [Abstract][Full Text] [Related]
18. 2,3'4,4',5-Pentachlorobiphenyl induces hepatocellular carcinoma cell proliferation through pyruvate kinase M2-dependent glycolysis.
Liang W; Zhang Y; Song L; Li Z
Toxicol Lett; 2019 Oct; 313():108-119. PubMed ID: 31251971
[TBL] [Abstract][Full Text] [Related]
19. DMFC (3,5-dimethyl-
Xiang J; Wang Z; Liu Q; Li X; Sun J; Fung KP; Liu F
Apoptosis; 2017 Mar; 22(3):381-392. PubMed ID: 27873035
[TBL] [Abstract][Full Text] [Related]
20. Insulin promotes hepatocarcinoma tumorigenesis by up-regulating PKM2 expression.
Liu J; Zhi Q; Liu Y; Wang Y; Chen L; Ke Y; Zeng L; Wu X; Yang X; Guleng B; Liu H; Ren J
Exp Cell Res; 2021 Nov; 408(2):112872. PubMed ID: 34648844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
